cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	submitter	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id	comment
			CASRLLAGGDNEQFF			TRBJ2-1*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	antigen-loaded-targets		amplicon-seq				CD8+	0.12% of Pentamer+ CD8 T cells, 0.1% of CD137+ CD8 T cells, 0.03% of Proliferating(day 6) CD8 T cells				1	pp65(495)	PBMC				Full sequence: NQTSLYFCASRLLAGGDNEQFFGPGTRLTV, V-segment is not specified, see the article for details
			CASSAYTGTVYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	antigen-loaded-targets		amplicon-seq				CD8+	0.1% of Pentamer+ CD8 T cells, 0.02% of CD137+ CD8 T cells, 0.02% of Proliferating(day 6) CD8 T cells				2	pp65(495)	PBMC				Full sequence: SQTSVYFCASSAYTGTVYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSLSTGTSYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	antigen-loaded-targets		amplicon-seq				CD8+	0.09% of Pentamer+ CD8 T cells, 0.06% of CD137+ CD8 T cells, 0.07% of Proliferating(day 6) CD8 T cells				3	pp65(495)	PBMC				Full sequence: PSQTSVYFCASSLSTGTSYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSEALLGRANYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	0.95% of Pentamer+ CD8 T cells, 0.58% of CD137+ CD8 T cells, 0.16% of Proliferating(day 6) CD8 T cells				4	pp65(495)	PBMC				Full sequence: DSAMYFCASSEALLGRANYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSLAPGTTNEKLFF			TRBJ1-4*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	0.33% of Pentamer+ CD8 T cells, 0.24% of CD137+ CD8 T cells, 0.08% of Proliferating(day 6) CD8 T cells				5	pp65(495)	PBMC				Full sequence: RDSAMYRCASSLAPGTTNEKLFFGSGTQLSV, V-segment is not specified, see the article for details
			CASSPGQTFSNQPQHF			TRBJ1-5*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	antigen-loaded-targets		amplicon-seq				CD8+	0% of Pentamer+ CD8 T cells, 0.05% of CD137+ CD8 T cells, 0.01% of Proliferating(day 6) CD8 T cells				6	pp65(495)	PBMC				Full sequence: GDSALYFCASSPGQTFSNQPQHFGDGTRLSI, V-segment is not specified, see the article for details
			CASSPLTGTGVYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	49.5% of Pentamer+ CD8 T cells, 40.95% of CD137+ CD8 T cells, 62.23% of Proliferating(day 6) CD8 T cells				7	pp65(495)	PBMC				Full sequence: SQTSVYFCASSPLTGTGVYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSPTTGTGNYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	antigen-loaded-targets		amplicon-seq				CD8+	0.06% of Pentamer+ CD8 T cells, 0.09% of CD137+ CD8 T cells, 0.14% of Proliferating(day 6) CD8 T cells				8	pp65(495)	PBMC				Full sequence: SQTSVYFCASSPTTGTGNYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSSSFPGGGNEQFF			TRBJ2-1*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	0.57% of Pentamer+ CD8 T cells, 0.21% of CD137+ CD8 T cells, 0.1% of Proliferating(day 6) CD8 T cells				9	pp65(495)	PBMC				Full sequence: EDSAVYLCASSSSFPGGGNEQFFGPGTRLTV, V-segment is not specified, see the article for details
			CASSYATGASYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	1.72% of Pentamer+ CD8 T cells, 1.67% of CD137+ CD8 T cells, 2.16% of Proliferating(day 6) CD8 T cells				10	pp65(495)	PBMC				Full sequence: PSQTSVYFCASSYATGASYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSYQTGAAYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	0.9% of Pentamer+ CD8 T cells, 0.83% of CD137+ CD8 T cells, 0.94% of Proliferating(day 6) CD8 T cells				11	pp65(495)	PBMC				Full sequence: PSQTSVYFCASSYQTGAAYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASSYQTGASYGYTF			TRBJ1-2*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	24.7% of Pentamer+ CD8 T cells, 20.38% of CD137+ CD8 T cells, 32.45% of Proliferating(day 6) CD8 T cells				12	pp65(495)	PBMC				Full sequence: PSQTSVYFCASSYQTGASYGYTFGSGTRLTV, V-segment is not specified, see the article for details
			CASTLLGGAGYNEQFF			TRBJ2-1*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	antigen-loaded-targets		amplicon-seq		antigen-loaded-targets		CD8+	0.09% of Pentamer+ CD8 T cells, 1.95% of CD137+ CD8 T cells, 0.21% of Proliferating(day 6) CD8 T cells				13	pp65(495)	PBMC				Full sequence: GDSALYFCASTLLGGAGYNEQFFGPGTRLTV, V-segment is not specified, see the article for details
			CQQLLFSGGGNEQFF			TRBJ2-1*01	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:24069285	Anastasiia Sycheva	pentamer-sort		amplicon-seq		antigen-loaded-targets		CD8+	0.46% of Pentamer+ CD8 T cells, 0.16% of CD137+ CD8 T cells, 0.06% of Proliferating(day 6) CD8 T cells				14	pp65(495)	PBMC				Full sequence: GGLRRVSLCQQLLFSGGGNEQFFGPGTRLTV, V-segment is not specified, see the article for details
